Role of gene therapy in tissue engineering procedures in rheumatology: The use of animal models

Biomaterials

Volumn 25, Issue 9, 2004, Pages 1497-1504

  Van Der Kraan, Peter M ^a   Van De Loo, Fons A J ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Cytokines; Gene therapy; Growth factors; Rheumatic diseases

Indexed keywords

CELLS; DISEASES; GENES; METABOLISM; PHYSIOLOGICAL MODELS; TISSUE;

TISSUE ENGINEERING;

BIOMATERIALS;

CYTOKINE; PROTEINASE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL FACTOR; ENZYME DEGRADATION; EXPERIMENTAL TEST; GENE OVEREXPRESSION; GENE THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RHEUMATIC DISEASE; RHEUMATOLOGY; SYSTEM ANALYSIS; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REPAIR; TRANSGENE;

ANIMALIA;

EID: 0347754992     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00493-9     Document Type: Article

References (59)

1. Maini N.M., Feldmann M. Immunopathogenesis of rheumatoid arthritis. Maddison P.J., Isenberg D.A., Woo P., Glass D.N. Oxford textbook of rheumatology. 1998;983-1004 Oxford University Press, Oxford.
2. Doherty M., Jones A., Cawston T.E. Osteoarthritis. Maddison P.J., Isenberg D.A., Woo P., Glass D.N. Oxford textbook of rheumatology. 1998;1515-1553 Oxford University Press, Oxford.
3. Joosten L.A.B., Helsen M.M.A., van de Loo F.A.J., van den Berg W.B. Anticytokine treatment of established collagen-induced arthritis in DBA/I mice. A comparative study using anti-TNFα, antiIL-1α/β, and IL-1RA. Arthritis Rheum. 39:1996;797-808.
4. Van den Berg W.B., Joosten L.A.B., Helsen M.M.A., van de Loo F.A.J. Amelioration of established murine collagen induced arthritis witj antiIL-1 treatment. Clin Exp Immunol. 95:1994;237-243.
5. Williams R.O., Feldmann M., Maini R.N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Nat Acad Sci USA. 89:1992;9784-9788.
6. Wooley P.H., Dutcher J., Widmer M.B., Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice. J Immunol. 151:1993;6602-6607.
7. Kuiper S., Joosten L.A., Bendele A.M., Edwards C.K. 3rd, Arntz O.J., Helsen M.M., Van de Loo F.A., Van den Berg W.B. Different roles of TNFα and IL-1 in murine streptococcal cell wall arthritis. Cytokine. 10:1998;690-702.
8. van de Loo F.A., Joosten L.A., van Lent P.L., Arntz O.J., van den Berg W.B. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:1995;164-172.
9. Otani K., Nita I., Macaulay W., Georgescu H.I., Robbins P.D., Evans C.H. Suppression of antigen-induced arthritis by gene therapy. J Immunol. 156:1996;3558-3562.
10. Trentham D.E., Townes A.S., Kang A.H. Autoimmunity to type II collagen. an experimental model of arthritis J Exp Med. 146:1977;857-868.
11. Bakker A.C., Joosten L.A.B., Arntz O.J., Helsen M.M.A., Bendele A.M., van de Loo F.A.J., van den Berg W.B. Prevention of murine collagen-induced arthritis in the knee and ipsilatral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthrits Rheum. 40:1997;893-900.
12. Bakker A.C., van de Loo F.A.J., Joosten L.A.B., Arntz O.J., Varley A.W., Munford R.S., van den Berg W.B. C3-tat/HIV regulated intraarticular human IL-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to CMV-regulated expression of the same transgene. Arthritis Rheum. 46:2002;1661-1670.
13. Quattrocchi E., Walmsley M., Browne K., Williams R.O., Marinova-Mutafchieva L., Buurman W., Butler D.M., Feldmann M. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. J Immunol. 163:1999;1000-1009.
14. Probert L., Plows D., Kontogeorgos G., Kollias G. The type I IL-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol. 25:1995;1794-1797.
15. Ghivizzani S.C., Oligino T.J., Glorioso J.C., Robbins P.D., Evans C.H. Direct gene delivery strategies for the treatment of rheumatoid arthritis. Drug Discov Today. 6:2001;259-267.
16. Lubberts E., Joosten L.A., van Den Bersselaar L., Helsen M.M., Bakker A.C., van Meurs J.B., Graham F.L., Richards C.D., van Den Berg W.B. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol. 163:1999;4546-4556.
17. Jorgensen C., Apparailly F., Canovas F., Verwaerde C., Auriault C., Jacquet C., Sany J. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum. 42:1999;678-685.
18. Muller-Ladner U., Evans C.H., Franklin B.N., Roberts C.R., Gay R.E., Robbins P.D., Gay S. Gene transfer of cytokine inhibibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum. 42:1999;490-497.
19. Neumann E., Judex M., Kullmann F., Grifka J., Robbins P.D., Pap T., Gay R.E., Evans C.H., Scholmerich J., Muller-Ladner U. Inhibition of cartilage destruction by double gene transfer of IL-1RA and IL-10 involves the activin pathway. Gene Ther. 9:2002;1508-1519.
20. Woods J.M., Amin M.A., Katschke K.J., Volin M.V., Ruth J.H., Connors M.A., Woodruff D.C., Kurata H., Arai K., Haines G.K., Kumar P., Koch A.E. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced artrhritis. Hum Gene Ther. 13:2002;381-393.
21. Tomita T., Takeuchi E., Tomita N., Morishita R., Kaneko M., Yamamoto K., Nakase T., Seki H., Kato K., Kaneda Y., Ochi T. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligonucleotides as a gene therapy. Arthritis Rheum. 42:1999;2532-2542.
22. Tak P.P., Gerlag D.M., Aupperle K.R., van de Geest D.A., Overbeek M., Bennett B.L., Boyle D.L., Manning A.M., Firestein G.S. Inhibitor of nuclear factor κB kinase beta is a key regulator of synovial uinflammation. Arthritis Rheum. 44:2001;1897-1907.
23. Van der Laan W.H., Pap T., Ronday H.K., Grimbergen J.M., Huisman L.G., Tekoppele J.M., Breedveld F.C., Gay R.E., Gay S., Huizinga T.W., Verheijne J.H., Quax P.H. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene tranfer of a cell surface-targeted plasmin inhibitor. Arthritis Rheum. 43:2000;1710-1718.
24. Schett G., hayer S., Tohidast-Akrad M., Schmid B.J., Lang S., Turk B., Kainberger F., Haralambous S., Kollias G., Newby A.C., Xu Q., Steiner G., Smolen J. Adenovirus-based issue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum. 44:2001;2888-2898.
25. Apparailly F., Noel D., Millet V., Baker A.H., Lisignoli G., Jacquet C., Kaiser M.J., Sany J., Jorgensen C. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis. Arthritis Rheum. 44:2001;1444-1454.
26. Mi Z., Ghivizzani S.C., Lechman E.R., Jaffurs D., Glorioso J.C., Evans C.H., Robbins P.D. Adenovirus-mediated gene transfer of insulin-like growth factor-I stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum. 43:2000;2563-2570.
27. Van Beuningen H.M., Glansbeek H.L., Morris E.A., van der Kraan P.M., van den Berg W.B. Differential effects of local application of BMP-2 or TGF-β on both articular cartilage composition and osteophyte formation. Osteoarthritis Cart. 6:1998;306-317.
28. Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., van den Berg W.B. Stimulation of articular cartilage repair in established arthyritis by local administration of transforming growth factor β into murine knee joints. Lab Invest. 78:1998;133-142.
29. Bakker A.C., van de Loo F.A.J., van Beuningen H.M., Sime P., van Lent P.L.E.M., van der Kraan P.M., Richards C.D., van den Berg W.B. Overexpression of active TGF β1 in the murine knee joint. Evidence for synovial layer dependent chondro-osteophyte formation. Osteoarthritis Cart. 9:2001;128-136.
30. Van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1. age related differences Ann Rheum Dis. 53:1994;593-600.
31. Glansbeek H.J., van Beuningen H.M., Vitters E.L., Morris E.A., van der Kraan P.M., van den Berg W.B. BMP-2 stimulates articular proteoglycan synthesis in vivo but is not able to counteract IL-1 effects on proteoglycan synthesis and content. Arthritis Rheum. 40:1997;1020-1028.
32. Van der Kraan P.M., Vitters E.L., van Beuningen H.M., van de Loo F.A., van den Berg W.B. Role of nitric oxide in the inhibition of BMP-2-mediated stimulation of proteoglycan synthesis in articular cartilage. Osteoarthritis Cart. 8:2000;82-86.
33. Majumdar M.K., Wang E., Morris E.A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol. 189:2001;275-284.
34. Van Beuningen H.M., Glansbeek H.L., Morris E.A., van der Kraan P.M., van den Berg W.B. Differential effects of local application of BMP-2 or TGF- on both articular cartilage composition and osteophyte formation. Osteoarthritis Cart. 6:1998;306-317.
35. Van den Berg WB, van der Kraan PM, van Beuningen HM. Growth factors and cartilage repair in OA. In: Reginster JY, Pelltier JP, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis. Clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 185-207.
36. Bakker A.C., van de Loo F.A.J., van Beuningen H.M., Sime P., van Lent P.L.E.M., van der Kraan P.M., Richards C.D., van den Berg W.B. Overexpression of active TGF β1 in the murine knee joint. Evidence for synovial layer dependent chondro-osteophyte formation. Osteoarthritis Cart. 9:2001;128-136.
37. Scharstuhl A., Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., van den Berg W.B. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol. 69:2002;507-514.
38. Roessler B.J., Allen E.D., Wilson J.M., Hartman J.W., Davidson B.L. Adenoviral-mediated gene tranfer to rabbit synovium in vivo. J Clin Invest. 92:1993;1085-1092.
39. Bakker A.C., van de Loo F.A.J., Joosten L.A.B., Bennink M.B., Arntz O.J., Dmitriev I.P., Kashentsera E.A., Curiel D.T., van den Berg W.B. A tropism modified adenoviral vector increased the effectivity of gene therapy for arthritis. Gene Ther. 8:2001;1785-1793.
40. Reynolds P.N., Dmitriev I., Curiel D.T. Insertion of an RGD motif into the H1 loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administerd vector. Gene Ther. 6:1999;1336-1339.
41. Ohashi S., Kubo T., Kishida T., Ikeda T., Takahashi K., Arai Y., Terauchi R., Asada H., Imanishi J., Mazda O. Succesful genetic transduction in vivo into synovium by means of electroporation. Biochem Biophys Res Commun. 2293:2002;1530-1535.
42. Van Lent P.L.E.M., van den Berg W.B., Schalkwijk J., van de Putte L.B.A., van de Bersselaar L. The impact of protein size and charge on its retention in articular cartilage. J Rheumatol. 14:1987;798-805.
43. Tomita T., Hashimoto H., Tomita N., Morishita R., Lee S.B., Hayashida K., Nakamura N., Yonenobu K., Kaneda Y., Ochi T. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum. 40:1997;901-906.
44. Goater J., Muller R., Kollias G., Firestein G.S., Sanz I., O'Keefe R.J., Schwarz E.M. Empirical advantages of adeno associated viral vectors in viv gene therapy fro arthritis. J Rheumatol. 27:2000;983-989.
45. Ulrich-Vinther M., Maloney M.D., Goater J.J., Soballe K., Goldring M.B., O'Keefe R.J., Schwarz E.M. Light-activated gene transduction enhances adeno-assocated virus vector-mediated gene expression in human articular chondrocytes. Arthritis Rheum. 46:2002;2095-2104.
46. Baragi V.M., renckiewicz R.R., Qiu L., Brammer D., Riley J.M., Sigler R.E., Frenkel S.R., Amin A., Abramson S.B., Roessler B.J. Transplantation of adenovirally transduced allogenic chondrocytes into cartilage defects in vivo. Osteoarthritis Cart. 5:1997;275-282.
47. Bandara G., Mueller G.M., Galea-Lauri J., Tindal M.H., Georgescu H.I., Suchanek M.K., Hung G.L., Glorioso J.C., Robbins P.D., Evans C.H. Intraarticular expression of biologically active interleukin-1-receptor- antagonist protein by ex vivo gene transfer. Proc Nat Acad Sci USA. 90:1993;10764-10768.
48. Evans C.H., Robbins P.D. Gene therapy in arthritis. Internal Med. 38:1999;233-239.
49. Ghivizzani S.C., Lechman E.R., Kang R., Tio C., Kolls J., Evans C.H., Robbins P.D. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Nat Acad Sci USA. 95:1998;4613-4618.
50. Le C.H., Nicolson A.G., Morales A., Sewell K.L. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of amodified tumor necrosis factor alpha receptor gene. Arthritis Rheum. 40:1997;1662-1669.
51. Woods J.M., Katschke K.J., Volin M.V., Ruth J.H., Woodruff D.C., Amin M.A., Connors M.A., Kurata H., Arai K., Haines G.K., Kumar P., Koch A.E. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol. 166:2001;1214-1222.
52. Kim S.H., Kim S., Evans C.H., Ghivizzani S.C., Oligino T., Robbins P.D. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol. 166:2001;3499-3505.
53. Lubberts E., Joosten L.A., Chabaud M., van Den Bersselaar L., Oppers B., Coenen-De Roo C.J., Richards C.D., Miossec P., van Den Berg W.B. Gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest. 105:2000;1697-1710.
54. Boyle D.L., Nguyen K.H., Zhuang S., Shi Y., McCormack J.E., Chada S., Firestein G.S. Intra-articular IL-4 gene therapy in arthritis. anti-inflammatory effect and enhanced th2 activity Gene Ther. 6:1999;1911-1918.
55. Apparailly F., Verwaerde C., Jacquet C., Auriault C., Sany J., Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol. 160:1998;5213-5220.
56. Ma Y., Thornton S., Duwel L.E., Boivin G.P., Giannini E.H., Leiden J.M., Bluestone J.A., Hirsch R. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol. 161:1998;1516-1524.
57. Jorgensen C., Noel D., Apparailly F., Sany J. Stem cells for repair of cartilage and bone. the next challenge in osteoarthritis and rheumatoid arthritis Ann Rheum Dis. 60:2001;305-309.
58. Fusenegger M. The impact of mammalian gene regulation concepts on functional geneomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog. 17:2001;1-51.
59. Smits P., Li P., Mandell J., Zhang Z., Deng J.M., Behringer R.R., de Crombrugge B., Lefebvre V. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 1:2001;277-290.